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Summary
Objective: To compare the actions of ﬁbroblast growth factor-basic (bFGF), insulin-like growth factor-I (IGF-I), platelet derived growth factor-
AB (PDGF-AB), and transforming growth factor-beta 1 (TGF-b1) on bovine meniscus tissue explants with and without static mechanical
compression.
Design: Meniscus tissue explants were cultured in a serum-free environment supplemented with an individual growth factor (1) over a range
of concentrations for 4 days, (2) at a single concentration for 2e14 days, and (3) at a single concentration for 4 days coupled with graded levels
of static compression. Explants were analyzed for accumulation of newly synthesized proteoglycan and total protein as measured by
35S-sulfate and 3H-proline incorporation, respectively.
Results: Over the range of chosen concentrations, TGF-b1 was the most potent stimulator of both protein and proteoglycan production,
whereas bFGF was the least effective stimulator. Over a 2-week period for all four growth factors, the stimulation of proteoglycan production
was sustained while there was no stimulation of protein production during this period. The superposition of static mechanical compression
inhibited matrix production in the presence of each anabolic factor, with comparable inhibition relative to uncompressed controls for all factors.
Conclusions: The growth factors chosen exhibited an anabolic effect on the meniscus tissue explants, encouraging matrix production and
deposition. The addition of static mechanical compression produced comparable relative inhibition of matrix production for each growth factor,
suggesting that static compression and growth factors may modulate meniscal ﬁbrochondrocyte biosynthesis via distinct pathways.
 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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The menisci are ﬁbrocartilaginous organs in the knee joint
that are responsible for distributing roughly 50e70% of the
load through the knee1. Other functions include the
maintenance of joint stability and lubrication2. The tissue
is highly hydrated (70e80%), and the main mechanically
functional extracellular matrix components are collagen
type I and proteoglycans2. These components make up
roughly 70%2e4 and 1e3%5e8, respectively, of the dry
weight of the matrix and are arranged in a highly ordered
ultrastructure well suited for the tissue function. The outer
region of the meniscus contains circumferentially oriented
collagen ﬁber bundles capable of resisting tensile hoop
stresses due to joint loading. The inner region is pro-
teoglycan rich and is effective for resisting direct compres-
sive loads2,5. This matrix is produced by meniscal
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Received 24 July 2003; revision accepted 14 May 2004.73ﬁbrochondrocytes9 which exhibit behaviors similar to both
ﬁbroblasts and chondrocytes.
The vascular supply of the mature meniscus is limited to
the outer one-third of the organ (referred to as the ‘‘red-
zone’’). The remaining two-thirds (referred to as the ‘‘white-
zone’’) is primarily avascular and has a small propensity for
autonomous repair in response to injury10e13. Access to the
vascular supply has been shown to be critical for promoting
autonomous repair of the meniscus11,14. Speciﬁc growth
and differentiation factors that may be contained within the
vasculature have been identiﬁed in the healing and
reparative mechanisms of meniscus tissue, speciﬁcally in
stimulating ﬁbrochondrocytes to produce necessary matrix
components15,16. Common clinical repair techniques to
increase the healing potential of a meniscus tear include
debridement and the creation of vascular access chan-
nels17, allowing a conduit to the vascular supply rich in
these factors.
In vitro, growth factors have been noted to heavily
inﬂuence the behavior of ﬁbrochondrocytes in monolayer
and explant culture18e24. Webber et al. found that the use
of basic ﬁbroblast growth factor (bFGF) at 10 ng/mL and
ascorbate at 40 mg/mL caused ﬁbrochondrocytes cultured
in monolayer to proliferate, whereas using only ascorbate
shifted the cells towards increases in matrix deposition,
speciﬁcally increases in sulfated glycosaminoglycans
(sGAG)18. Platelet derived growth factor-AB (PDGF-AB)
has been shown to induce a mitogenic response in6
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migration amongst ﬁbrochondrocytes in monolayer cul-
ture22. In addition, Bhargava et al. found that insulin-like
growth factor-1 (IGF-I) stimulated migration of isolated
ﬁbrochondrocytes only from the ‘‘red-white zone’’22. Collier
and Ghosh found increased stimulation of proteoglycan
production by ﬁbrochondrocytes in monolayer and explant
culture with the addition of TGF-b1 over serum-free media
and media containing 10% fetal bovine serum, respec-
tively20.
In vivo, the majority of the ﬁbrochondrocytes rely upon
diffusion and mechanically driven convection through the
extracellular matrix for nutrient delivery. The synovial
environment is rich in nutrients and serves as a repository
for cellular waste products. In addition, the paracrine effects
of soluble factors produced by the ﬁbrochondrocytes them-
selves are partially modulated by the transport phenomena
within the matrix. Recognizing speciﬁc growth factors as
major stimulators of cartilaginous extracellular matrix
growth, it is important to characterize their actions and
potency on ﬁbrochondrocytes in their native tissue matrix.
Therefore, this study explores the individual effects of four
growth factors (bFGF, IGF-I, PDGF-AB, and TGF-b1) on
meniscus tissue explants under serum-free culture con-
ditions. The ﬁrst aim of this study was to obtain the
doseeresponses of the meniscus explants to ranges of
concentrations of each growth factor. Next, the temporal
effects of these factors at a single concentration were
explored for up to 2 weeks. Finally, the actions of the growth
factors in the presence of graded levels of static mechanical
compression were examined to explore the interactions,
if any, between the two stimuli.
Methods
MATERIALS
Bovine stiﬂe joints were from Research 87 (Marlborough,
MA). High glucose Dulbecco’s Modiﬁed Eagle’s Medium
(DMEM), penicillin, streptomycin, neomycin, kanamycin
sulfate, Fungizone, gentamicin, phosphate buffered saline
(PBS), HEPES buffer, non-essential amino acids (NEAA),
and L-proline were from Invitrogen (Carlsbad, CA). Bovine
serum albumin (BSA), ascorbic acid, sodium sulfate,
ammonium acetate, and Hoechst 33258 dye were from
Sigma (St. Louis, MO). 1,9-Dimethyl-methylene blue
(DMMB) dye was from Aldrich Chemical Company (Mil-
waukee, WI). 35S-sodium sulfate was from American
Radiolabeled Chemicals (St. Louis, MO) or ICN Biomed-
icals, Inc. (Irvine, CA). L-5-3H-proline was from American
Radiolabeled Chemicals (St. Louis, MO) or Amersham
Biosciences (UK). Recombinant human forms of bFGF
(17.2 kDa), IGF-I (7.6 kDa), PDGF-AB (25.5 kDa), and
TGF-b1 (25.0 kDa) were from PeproTech (Rocky Hill, NJ).
Proteinase K was from FisherBiotech (Fair Lawn, NJ).
Biopsy punches were from Miltex Instruments (Lake
Success, NY).
TISSUE EXPLANTS
Full thickness meniscus cores were excised with 4 mm
diameter biopsy punches from the lateral and medial
menisci of immature (2e4 week) bovine stiﬂe joints
[Fig. 1]. In preliminary studies, we found that IGF-Isupplementation and static compression induced compara-
ble changes in 35S-incorporation for explants from the inner
and outer regions of both medial and lateral menisci, with no
statistically signiﬁcant differences based on location. There-
fore, explants from the midsubstance of both menisci were
randomly allocatedacross experimental groups.Usinga cus-
tom designed slotted cutting block and sterile razor blades,
the cores were sliced into either 1-mm (doseeresponse and
timeecourse studies) or 2-mm-thick discs (static compres-
sion studies). Approximately 1 mmof the superﬁcial most top
and bottom layers of each core was discarded to remove the
structurally distinct surface layers. The discs were ﬁrst
soaked in DMEM supplemented with 50 mg/mL gentamicin,
50 mg/mL penicillin, 50 mg/mL streptomycin, 100 mg/mL
neomycin, 100 mg/mL kanamycin sulfate, and 0.25 mg/mL
Fungizone for 24 h in a 37(C, 5% CO2 incubator. The
explants were then precultured in basal serum-free culture
medium (DMEM plus 0.1% BSA, 50 mg/mL gentamicin,
0.1 mM NEAA, 1.0 mM HEPES, 4 mM L-proline, and
50 mg/mL ascorbic acid) for 3 days to allow for equilibration
of all samples.
STATIC COMPRESSION
Tissue explants were compressed within custom de-
signed polycarbonate static compression chambers [Fig.
2(A)]. Each chamber base held up to 16 samples in
individual wells (15 mm diameter!10 mm), and samples
were compressed between the well bottoms and 8 mm
diameter impermeable platens attached to the lid [sche-
matically shown in Fig. 2(B)]. Three stainless steel spacing
blocks and a central annular spacer were used to limit the
compression imparted by the platens upon the tissue ex-
plants. The chamber assembly was placed on an aluminum
platform and a nut and washer assembly was used to slowly
tighten the chamber lid to the platform/base assembly. After
the initial tightening of the chamber lid, appropriate culture
media were added to the chamber wells via the medium
ports on the chamber lid. These ports allowed for the
aspiration of old media and addition of fresh media while
maintaining compression of the samples.
BIOSYNTHESIS MEASUREMENTS
During the ﬁnal 21 h of each culture period, culture media
were supplemented with 20 mCi/mL of L-5-3H-proline and
10 mCi/mL of 35S-sodium sulfate to measure the accumu-
lation of newly synthesized proteins ( primarily collagen)
and proteoglycans, respectively. Explants were then re-
moved and washed 4 times for 30 min each time in PBS
supplemented with 0.8 mM sodium sulfate and 1 mM
L-proline at 4(C in order to rinse out unincorporated
isotopes. Samples were lyophilized and digested in 1 mg
of proteinase K (0.2e0.4 mg/mL in 100 mM ammonium
acetate) per 80 mg of tissue explant at 60(C overnight.
Digests were assayed for radiolabel content with an
LS5000TD liquid scintillation counter (Beckman, Fullerton,
CA). Data for each sample were normalized by total DNA
content as determined by the ﬂuorescent Hoechst 33258
dye assay25 read on a Spectra Max Gemini ﬂuorescent
plate reader (Molecular Devices, Sunnyvale, CA). Digests
and spent media were also assayed for sGAG content as
determined by the 1,9-DMMB dye assay26 read on a Power
Wave 340X-I plate reader (Bio-Tek, Winooski, VA).
738 S. M. Imler et al.: Effects of growth factors and compression on meniscus tissue explantsFig. 1. Explant process showing meniscus explants from the lateral and medial menisci of immature bovine stiﬂe joints. Meniscus cores were
sliced to produce 1-mm or 2-mm-thick discs, discarding the inferior and superior superﬁcial layers.EXPERIMENTAL DESIGN
Study 1, doseeresponse
The ﬁrst series of studies examined the response of
meniscus explants to stimulation with a range of concen-
trations of each growth factor. Four concentrations of each
growth factor spanning two orders of magnitude were
chosen (Table I) based on previous studies in the literature
involving cartilage tissue or isolated chondrocytes27e33.
Four separate ‘‘sub-studies’’ were conducted, each of which
utilized tissue from a different animal and included a control
explant group cultured in basal medium alone (BSA
controls). Study 1a included treatments with bFGF at
1e300 ng/mL (0.0581e17.4 nM), IGF-I at 30e1000 ng/mL
(3.95e132 nM), or TGF-b1 at 0.05e5 ng/mL (0.002e0.2
nM). Study 1b included treatments with IGF-I at
30e1000 ng/mL or PDGF-AB at 3e300 ng/mL (0.118e11.8
nM). Study 1c included treatments with all four growth
factors at the previously stated concentration ranges.
Following the initial preculture in basal medium, the tissue
explants (1 mm thick, N ¼ 6 per condition in each study,
total N ¼ 12e18 per condition) were cultured for 4 days in
1.0 mL each of appropriately supplemented medium. A
fourth study (study 1d, N ¼ 6 per condition) was performed
to explore a higher range of concentrations of TGF-b1 at
1e100 ng/mL (0.04e4.0 nM) based on the results of the
ﬁrst doseeresponse studies.Study 2, timeecourse
The second study compared the duration of stimulation
for up to 2 weeks by a single concentration (Table I) of each
growth factor. After preculture, tissue explants from a single
animal (1 mm thick, N ¼ 5 per condition per time point)
were cultured for 2, 4, 7, or 14 days in basal media plus
bFGF at 100 ng/mL (5.81 nM), IGF-I at 200 ng/mL
(26.3 nM), PDGF-AB at 100 ng/mL (3.92 nM), or TGF-b1
at 5 ng/mL (0.2 nM). Control explants were cultured in basal
medium alone (BSA controls). In addition, spent media
were assayed for sGAG release.
Study 3, static compression
The third study examined the effects on matrix synthesis
of static compression combined with growth factor supple-
mentation (Table I): bFGF at 100 ng/mL (5.81 nM), IGF-I at
100 ng/mL (13.2 nM), PDGF-AB at 100 ng/mL (3.92 nM), or
TGF-b1 at 50 ng/mL (2.0 nM). After preculture, tissue
explants (2 mm thick, N ¼ 6 per condition) were cultured
for 4 days in basal media with or without a single con-
centration of growth factor under static compression to
100%, 75%, or 50% of the original cut thickness (hereafter
referred to as 0%, 25%, or 50% compression, respectively).
These static compression levels were chosen both to span
the range required to produce a consistent inhibitoryFig. 2. Static compression chamber. (A) Individual explants were placed in isolated wells in the base and compressed between the base and
platens on the lid. (B) Schematic showing the cross-section of a single well containing an explant and feed medium.
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cartilage literature34e36. In addition, while the highest levels
of compression appear to be non-physiologic, these levels
could be seen in vivo due to prolonged exposure to loading.
Two sub-studies were conducted using tissue from two
different animals. During the preculture period, the explants
swelled such that compression to the original cut thickness
did impart a slight compressive deformation on the
samples. Control free swell (FS) explants were cultured in
a well of a culture dish.
STATISTICAL ANALYSIS
For all studies, the analyzed data were in the form of
incorporation rates normalized to DNA content. Data are
presented as values normalized to the average of a control
group, but all statistical analyses were performed on non-
normalized data. Doseeresponse data were analyzed
separately for each individual growth factor, with the BSA
control group included as a concentration of 0 ng/mL. Data
were analyzed using a two factor (sub-study and growth
factor level) General Linear Model (GLM) and Tukey’s test
for post hoc analysis using Minitab Release 12.23 (Minitab
Inc., State College, PA). Timeecourse data were analyzed
using a two factor (day and growth factor treatment) GLM
and Tukey’s test. Static compression data were analyzed
using a three factor (sub-study, growth factor treatment, and
compression level) GLM and Tukey’s test. For the IGF-I
doseeresponse and static compression studies, where
each sub-study did not include identical treatments, sub-
study was treated as a nested variable. Differences were
deemed signiﬁcant at P!0:05. All data are presented as
mean+standard error of the mean (S.E.M.).
Results
DOSE-DEPENDENT STIMULATION OF TISSUE EXPLANTS
In general, the tissue explants responded to increasing
levels of each growth factor with a dose-dependent
stimulation of matrix production. Figure 3 illustrates both
35S-sulfate and 3H-proline incorporation rates for all growth
factors normalized by the BSA controls.
For IGF-I and PDGF-AB [Fig. 3(A, B)], the dosee
responses appeared to plateau within the chosen concen-
tration ranges for both the 35S and 3H incorporation rates.
IGF-I obtained maximal levels of stimulation by 300 ng/mL
with 35S and 3H incorporation rates reaching 291% and
188% of BSA controls, respectively. The 35S incorporation
at 300 ng/mL IGF-I was signiﬁcantly higher than incorpora-
tion at 0 (P!0:0001), 30 (P!0:0001), and 100 ng/mL
(P ¼ 0:0040). The 3H incorporation at 100 ng/mL IGF-I was
signiﬁcantly higher than at 0 ng/mL (P ¼ 0:012), and at
Table I
Growth factor concentrations for each study
Growth
factor
Doseeresponse
(ng/mL)
Timeecourse
(ng/mL)
Static
compression
(ng/mL)
Low High
bFGF 1 300 100 100
IGF-1 30 1000 200 100
PDGF-AB 3 300 100 100
TGF-b1 0.05 5 5 50
1 100300 ng/mL IGF-I was signiﬁcantly higher than at 0
(P!0:0001) and 30 ng/mL (P ¼ 0:0008). PDGF-AB ob-
tained maximal levels of stimulation at 100 ng/mL with 35S
and 3H incorporation rates reaching 468% and 148% of
BSA controls, respectively. These maximal levels of stimu-
lation were both signiﬁcantly higher than incorporation rates
at any of the lower concentrations (all P!0:0002).
In contrast to IGF-I and PDGF-AB, the initial concentra-
tion range chosen for TGF-b1 (0.05e5 ng/mL) did not
appear to contain saturated incorporation of either 35S or 3H
[Fig. 3(C), open markers]. The 35S incorporation increased
monotonically with TGF-b1 concentration and still appeared
to be increasing at 5 ng/mL, the highest level in the initial
doseeresponse study. At 5 ng/mL, the 35S incorporation
rate was 640% of the BSA control value and was
signiﬁcantly greater than incorporation at any lower
concentration (all P!0:0001). In contrast, the 3H incorpo-
ration rate at 5 ng/mL was 161% of the BSA control value
and was only signiﬁcantly higher than at 0 (P!0:0001) and
0.05 ng/mL (P ¼ 0:0003). When the concentration range
was expanded to include concentrations of up to 100 ng/
mL, maximal levels of 35S and 3H incorporation were seen
at 100 ng/mL, reaching 1034% and 319% of BSA control
values, respectively [Fig. 3(C), solid markers]. The 35S
incorporation at 100 ng/mL TGF-b1 was signiﬁcantly higher
than at 0 (P!0:0001), 1 (P!0:0001), 5 (P ¼ 0:0070), and
10 ng/mL (P ¼ 0:0027). The 3H incorporation at 100 ng/mL
TGF-b1 was only signiﬁcantly higher than incorporation at
0 (P!0:0001) and 1 ng/mL (P ¼ 0:0003). However, the
response to TGF-b1 still did not appear to be truly saturated
by 100 ng/mL [Fig. 3(C)].
Finally, bFGF showed modest stimulation of 35S in-
corporation and no stimulation of 3H incorporation over the
chosen concentration range [Fig. 3(D)]. The 35S incorpora-
tion at 100 ng/mL bFGF was signiﬁcantly higher than at
0 ng/mL (P ¼ 0:0028), and the 35S incorporation at 300 ng/
mL was signiﬁcantly higher than at 0 (P!0:0001), 1
(P ¼ 0:0072), and 10 ng/mL (P ¼ 0:017). The greatest
35S incorporation occurred at 300 ng/mL, reaching 169%
of the BSA control value with no clear plateau in stimulation.
At these concentrations, bFGF did not signiﬁcantly affect 3H
incorporation (P ¼ 0:19).
Overall, the growth factors chosen were more potent
stimulators of 35S incorporation than of 3H incorporation.
There were differential levels of stimulation for the four
factors chosen. TGF-b1 was the most potent stimulator of
sulfate incorporation with an order of magnitude increase in
incorporation rate at the highest concentration. bFGF was
the least potent stimulator of both sulfate and proline
incorporation over the ranges studied.
STIMULATION OF TISSUE EXPLANTS OVER A 2-WEEK
CULTURE PERIOD
Based on the results of the initial doseeresponse study,
single concentrations of each growth factor (Table I) were
chosen to examine the effects of these factors over a 14-
day period. A signiﬁcant and sustained stimulation of 35S
incorporation over BSA controls was seen for TGF-b1,
IGF-I, and PDGF-AB (all P!0:0001), but not for bFGF
[P ¼ 0:51, Fig. 4(A)]. A signiﬁcant dip in 35S incorporation
was seen at day 7 (P ¼ 0:0031 vs day 4 and P ¼ 0:024 vs
day 14) for the TGF-b1 and PDGF-AB groups, but this was
not sustained (incorporation at day 14 was not signiﬁcantly
different from that on days 2 or 4, P > 0:90). In contrast,
none of the growth factor groups exhibited 3H incorporation
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Fig. 3. Doseeresponse results for concentration ranges of (A) IGF-I (B) PDGF-AB, (C) TGF-b1, and (D) bFGF. For presentation purposes,
data are normalized to basal medium (BSA) control values. In (C) solid markers and stars represent data from the second doseeresponse
study for TGF-b1. Star denotes that the value is signiﬁcantly different from BSA controls (P!0:05).signiﬁcantly different from the BSA controls [P ¼ 0:078 to
P ¼ 0:99, Fig. 4(B)], although the 3H incorporation for the
PDGF-AB group was signiﬁcantly less than that of the TGF-
b1 (P ¼ 0:0063) and IGF-I groups (P ¼ 0:0055). The 3H
incorporation at day 7 was also signiﬁcantly lower than at all
other days (all P!0:001).
As only a fraction of the newly synthesized matrix
molecules were incorporated into the tissue explants, we
also quantiﬁed the total sGAG released to the media over
the ﬁrst 12 days [Fig. 5]. The cumulative sGAG release data
for the TGF-b1 and PDGF-AB groups were generally
consistent with the 35S-sulfate incorporation data, with 12-
day cumulative sGAG releases of 221% and 133% of BSA
levels, respectively. TGF-b1 supplementation induced the
greatest 12-day cumulative sGAG release (P!0:012 vs. all
other groups). Interestingly, however, the cumulative sGAGreleased for the IGF-I and bFGF groups were lower than
that of the BSA group (73.2% and 43.7%, respectively),
despite the fact that both had higher 35S-sulfate incorpo-
rations than the BSA controls. This indicates that the
fraction of newly synthesized sGAG incorporated into the
extracellular matrix varied considerably between treatment
groups, suggesting that the growth factors differentially
inﬂuence assembly and processing of proteoglycans as
well as the overall synthesis rates.
INHIBITION OF MATRIX PRODUCTION WITH STATIC COMPRESSION
In the presence of any one growth factor, both the nor-
malized 35S and 3H incorporation rates were signiﬁcantly
inhibited for all static compression levels as compared to
the FS groups [P!0:0001, Fig. 6(A, B)]. IncreasingSulfate Incorporation
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Fig. 4. Timeecourse results for (A) sulfate and (B) proline incorporation rates over the 2-week culture period. For presentation purposes, data
are normalized to baseline BSA control values at day 0 ( following preculture but before adding growth factors).
741Osteoarthritis and Cartilage Vol. 12, No. 9compression levels induced a signiﬁcant dose-dependent
inhibition of 3H incorporation (P!0:0001), but not of 35S
incorporation (P > 0:46). Interestingly, although the overall
levels of 35S incorporation varied substantially among
media conditions, the dose-dependent inhibition of 3H
incorporation relative to FS incorporation levels did not
vary signiﬁcantly among media conditions (P ¼ 0:086).
Since the samples swelled during the preculture period,
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different from FS (P!0:05).explants in the 0% compression group were actually
compressed somewhat, resulting in signiﬁcant inhibitions
of 35S and 3H incorporation rates relative to FS controls for
all media conditions (P!0:0001). Although the swelling
was not quantiﬁed, this phenomenon is consistent with
previous observations in our laboratory37.
Discussion
The results of these studies illustrate the different effects
of four growth factors on matrix production by bovine
meniscus tissue explants. TGF-b1 was found to be the most
potent stimulator of both protein and proteoglycan matrix
accumulation, whereas bFGF was found to be the least
effective stimulator. For all factors, the stimulation of
proteoglycan accumulation was sustained over a 2-week
period, while protein accumulation was modestly stimulated
in the doseeresponse study and not signiﬁcantly stimulated
in the timeecourse study. The superposition of static
mechanical compression inhibited matrix accumulation in
the presence of each anabolic factor.
The concentration ranges chosen for the present studies
were based on published studies on articular cartilage
explants and chondrocytes in alginate bead and monolayer
cultures27e33. Although many studies have characterized
levels of these factors within the articular cartilage extra-
cellular matrix and synovial ﬂuid, little similar information for
the meniscus (or ﬁbrocartilage, in general) is currently
available. Luyten et al. estimated 50 ng of IGF-I per gram
(wet weight) of bovine articular cartilage28. This value is on
the same order of magnitude as the concentrations shown
to cause a plateau in matrix stimulation of articular
chondrocytes29,38,39. Schneiderman et al. found a lower
concentration of 10 ng total IGF-I per gram of adult human
articular cartilage40. bFGF has been found in articular
cartilage at concentrations of 1e50 ng per gram of tissue29.
PDGF has been identiﬁed as a locally produced factor, with
no traces of the growth factor in the circulation41. However,
in a study exploring the use of meniscal rasping as a
technique to promote healing within the avascular zone,
Ochi et al. detected the induction of the expression of both
TGF-b1 and PDGF using immunohistochemical staining42.
These factors were thought to play an important role in the
recruitment of ﬁbrochondrocytes and synoviocytes to
commence the repair process.
It should be noted that the choice of control conditions
(speciﬁcally, serum supplemented vs. deﬁned media) may
confound comparisons between studies. The presence of
serum increases the baseline synthesis rates and introdu-
ces the possibility of interactive effects with other cytokines
and growth factors in the serum. For example, the stimula-
tion of meniscus proteoglycan synthesis by TGF-b1 in the
current study was substantially greater than that previously
reported by Collier and Ghosh for mature ovine meniscus
tissue, who found a twofold increase over 10% fetal bovine
serum control levels with the addition of 4 ng/mL TGF-b120.
This is in contrast to a sixfold to sevenfold increase at
5 ng/mL TGF-b1 for bovine meniscus explants in the
current study and a threefold increase at 3 ng/mL for
porcine meniscus explants reported by Lietman et al. (both
over BSA controls)24.
Interestingly, the relative stimulation of meniscus
35S-sulfate incorporation by TGF-b1 was even more robust
than that previously reported for articular cartilage. Under
culture conditions similar to ours, Morales and Roberts
found that stimulation of immature bovine articular cartilage
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TGF-b1 with a sevenfold to eightfold increase over BSA
controls43. In contrast, the current doseeresponse study on
meniscus explants indicated a monotonic increase in 35S-
sulfate incorporation for doses up to 100 ng/mL of TGF-b1,
reaching a tenfold increase over BSA controls (to approx-
imately the level of cartilage explants in basal medium) with
no indication of a plateau in the response. This, along with
previous evidence that TGF-b1 stimulation of ﬁbrochondro-
cytes preferentially stimulates the production of large, ag-
gregating proteoglycans20, suggests that high doses of
TGF-b1 induce the production of amore cartilaginousmatrix.
Focusing on the mitogenic response, Spindler et al.
reported that PDGF-AB induced a tenfold increase in
proliferation by adult ovine explants from the outer one-
third but no signiﬁcant change in proliferation by explants
from the inner two-thirds, even with PDGF-AB supplemen-
tation at 200 ng/mL21. They suggested that the ﬁbrochon-
drocytes of the central region may not have the a-PDGF or
b-PDGF receptors necessary to interact with the exogenous
PDGF-AB. In the current study, neither PDGF-AB nor any
other factor signiﬁcantly increased explant DNA content
(data not shown). However, PDGF-AB did modulate the
biosynthesis of tissue explants from the midsubstance of
bovine menisci, suggesting that immature bovine ﬁbrochon-
drocytes do have functional PDGF receptors. This is
consistent with previous ﬁndings that PDGF stimulation of
both immature and mature bovine articular cartilage had no
inﬂuence on DNA synthesis but induced a dose-dependent
increase in proteoglycan biosynthesis44. It is also consistent
with the doseeresponse studies of Lietman et al. showing
a dose-dependent increase in proteoglycan biosynthesis of
porcine meniscus explants24.
The actions of bFGF on articular chondrocytes have been
identiﬁed as both mitogenic39,45 and biosynthetic29,39.
Osborn et al. found saturation in proteoglycan synthesis at
100e1000 ng/mL for adult bovine articular chondrocytes39,
with [3H]-thymidine incorporation also signiﬁcantly stimulat-
ed at the highest concentrations of bFGF. Sah et al. found
consistent results for adult bovine articular cartilage with
bFGF supplementation29, but found that matrix production
by immature bovine cartilage was stimulated only at a
concentration of 3 ng/mL of bFGF. Concentrations of 30e
300 ng/mL of bFGF caused an inhibition of both matrix pro-
duction and mitogenic activity and induced catabolism with
increases in proteoglycan release from the tissue matrix. In
contrast, we observed a signiﬁcant stimulation of pro-
teoglycan accumulation by immature meniscus explants
with up to 300 ng/mL of bFGF, indicating that cells in
the two tissues may respond in different manners to speciﬁc
stimuli.
Studies on articular cartilage explants have found
plateaus in IGF-I stimulation of proteoglycan synthesis from
20 to 200 ng/mL28,29,38,39. This wide range of concentra-
tions has been attributed to differences in immature vs.
mature tissue29,39, where mature tissue requires lower
concentrations of IGF-I for maximal responses in pro-
teoglycan production. Our results for immature ﬁbrocarti-
lage are on the same order of magnitude of the upper end of
that concentration range. While observing stimulation of
proteoglycan production in response to IGF-I, Luyten et al.
also found no change in DNA content over a 5-week-culture
period with IGF-I supplementation of immature (newborn to
10-month olds) articular cartilage explants28. Our results
were similar, with no signiﬁcant change in DNA content
normalized to explant dry weight over the 2-week-culture
period (data not shown).In addition to biochemical factors, biomechanical stimuli
aid in directing the development and maintenance of the
tissues within the knee joint. Bonassar et al. examined the
combined effects of mechanical compression and IGF-I
treatment on immature bovine articular cartilage explants.
IGF-I stimulation of both protein and proteoglycan synthesis
was reduced by static compression, and the time required
to reach steady-state stimulation was increased36. Overall,
however, the kinetics of IGF-I stimulation did not vary
substantially with compression level. Oscillatory compres-
sion substantially reduced the time to steady-state stimula-
tion by IGF-I, but this response was still substantially slower
than the biosynthetic response to oscillatory compression
alone46. Taken together, these studies suggest that stimu-
lation of articular cartilage by IGF-I and mechanical com-
pression occur through separate cellular mechanisms, with
the primary interaction being inhibition (static) or enhance-
ment (oscillatory) of IGF-I transport through the matrix.
Our results with meniscus tissue explants are consistent
with an analogous hypothesis for meniscal tissue. For all
four growth factors we observed an inhibition of matrix
accumulation relative to FS controls with the addition of
static compression at levels of 0%, 25%, and 50%. Despite
the wide range in stimulatory potentials, the relative inhi-
bition by static compression was comparable for all four
growth factors. This may indicate that, regardless of bio-
chemical stimulation, the inhibition caused by the bio-
mechanical stimulus has a greater and more potent effect
on the protein production of the cells. Our results appear to be
consistent with the notion that ﬁbrochondrocytes respond to
biochemical and biomechanical stimuli via separate cellular
pathways. Future short term studies examining the initial
kinetics of stimulation with and without mechanical compres-
sion will further clarify this issue.
These studies demonstrate the effects of several growth
factors, previously identiﬁed as having anabolic effects on
cartilage tissue explants, on the biosynthesis of meniscal
ﬁbrochondrocytes in meniscus tissue explants. Several
factors were identiﬁed as potent stimulators of meniscus
protein and proteoglycan accumulation, and the addition of
a biomechanical stimulus reduced the levels of biochemical
stimulation. While the results were generally similar to those
previously reported for articular cartilage, we observed
several differences in the responses. As the two tissues
occupy a common synovial environment in the knee joint,
care must be taken in employing growth factor-based repair
strategies for one tissue to ensure that a beneﬁcial treat-
ment for one tissue does not have detrimental effects on the
other. An improved understanding of environmental factors
capable of modulating meniscus metabolism will be crucial
in the development of improved biological strategies for
meniscus repair or regeneration.
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